SON-DP

SON-DP · Qurgen Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SON-DP, covering 2025-09-03 to 2025-09-03. Get the full timeline:

Most recent: Clinical Trial Update: SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors [Phase 1]

See pricing